CD19 and congenital rubella syndrome: Moreover, the absence of ITK has been shown to attenuate T cell migration to several peripheral organs, such as the intestine and brain (63–66), which may further contribute to reduced CRS and ICANS during ITK-KO CD19-CAR-T cell therapy.